Tag: Kathryn Vaughn
Patient Access: Consider taking active role
May 9, 2023Kathryn Vaughn
Q. What is market access and what is the value to me?
A. Pharma and biotech have long recognized the value of investing in market access to enable consumer access to therapies. As of recent, HME manufacturers have begun to invest in internal teams to address coverage and reimbursement restrictions with an overall goal of improving access for end-users. The work may take the form of advocacy on the federal level with CMS or with individual state Medicaid programs to improve coverage or reimbursement...
